Bitterroot Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$145M
- Investors
-
5
Bitterroot Bio General Information
Description
Operator of a biotechnology company intended to develop and deliver therapies for patients with cardiovascular disease. The company harnesses the immune system's natural ability to fight disease and through its research discovers the critical roles that immune cells and immune modulators play in the development and progression of cardiovascular disease, enabling medical professionals to access suitable medicines to transform the way cardiovascular diseases are treated.
Contact Information
Website
www.brbio.comCorporate Office
- 3160 Porter Drive
- Suite 220
- Palo Alto, CA 94304
- United States
Corporate Office
- 3160 Porter Drive
- Suite 220
- Palo Alto, CA 94304
- United States
Bitterroot Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 07-Jun-2023 | $145M | Completed | Pre-Clinical Trials |
Bitterroot Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
Bitterroot Bio Comparisons
Industry
Financing
Details
Bitterroot Bio Competitors (4)
One of Bitterroot Bio’s 4 competitors is Verve Therapeutics, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verve Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| Tenaya Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Tourmaline Bio | Formerly VC-backed | New York, NY |
Bitterroot Bio Patents
Bitterroot Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026148294-A1 | Treatment methods using sirp-alpha fc fusion polypeptides | Pending | 06-Jan-2025 | ||
| WO-2023183890-A1 | Multivalent sirp-alpha fusion polypeptides | Inactive | 24-Mar-2022 | ||
| JP-2025510774-A | Sirp-alpha fusion polypeptides having modified fc domains | Pending | 24-Mar-2022 | ||
| AU-2023240361-A1 | Sirp-alpha fusion polypeptides with modified fc domains | Pending | 24-Mar-2022 | ||
| EP-4499837-A1 | Sirp-alpha fusion polypeptides with modified fc domains | Pending | 24-Mar-2022 | C07K14/70503 |
Bitterroot Bio Signals
Bitterroot Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| GV | Corporate Venture Capital | Minority | ||
| Koch Disruptive Technologies | Venture Capital | Minority |
Bitterroot Bio Acquisitions (1)
Bitterroot Bio’s most recent deal was a Merger/Acquisition with Miga. The deal was made on 25-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Miga | 25-Apr-2025 | Merger/Acquisition | Diagnostic Equipment |
Bitterroot Bio Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Miga | San Francisco, CA | 2021 |
Bitterroot Bio FAQs
-
When was Bitterroot Bio founded?
Bitterroot Bio was founded in 2021.
-
Where is Bitterroot Bio headquartered?
Bitterroot Bio is headquartered in Palo Alto, CA.
-
What is the size of Bitterroot Bio?
Bitterroot Bio has 25 total employees.
-
What industry is Bitterroot Bio in?
Bitterroot Bio’s primary industry is Drug Discovery.
-
Is Bitterroot Bio a private or public company?
Bitterroot Bio is a Private company.
-
What is the current valuation of Bitterroot Bio?
The current valuation of Bitterroot Bio is .
-
What is Bitterroot Bio’s current revenue?
The current revenue for Bitterroot Bio is .
-
How much funding has Bitterroot Bio raised over time?
Bitterroot Bio has raised $145M.
-
Who are Bitterroot Bio’s investors?
Alexandria Venture Investments, ARCH Venture Partners, Deerfield Management, GV, and Koch Disruptive Technologies have invested in Bitterroot Bio.
-
Who are Bitterroot Bio’s competitors?
Verve Therapeutics, Cardurion, Tenaya Therapeutics, and Tourmaline Bio are competitors of Bitterroot Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process